Renaissance Technologies’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-112,800
Closed -$553K 3952
2024
Q2
$553K Sell
112,800
-42,600
-27% -$209K ﹤0.01% 2655
2024
Q1
$901K Sell
155,400
-15,100
-9% -$87.5K ﹤0.01% 2546
2023
Q4
$1.12M Buy
170,500
+37,800
+28% +$248K ﹤0.01% 2336
2023
Q3
$640K Buy
132,700
+800
+0.6% +$3.86K ﹤0.01% 2599
2023
Q2
$673K Buy
131,900
+28,100
+27% +$143K ﹤0.01% 2712
2023
Q1
$571K Buy
103,800
+22,800
+28% +$125K ﹤0.01% 2813
2022
Q4
$372K Buy
81,000
+9,100
+13% +$41.8K ﹤0.01% 3121
2022
Q3
$449K Sell
71,900
-31,494
-30% -$197K ﹤0.01% 2987
2022
Q2
$461K Sell
103,394
-77,397
-43% -$345K ﹤0.01% 3208
2022
Q1
$909K Buy
180,791
+162,291
+877% +$816K ﹤0.01% 2793
2021
Q4
$161K Sell
18,500
-147,100
-89% -$1.28M ﹤0.01% 3587
2021
Q3
$1.55M Buy
+165,600
New +$1.55M ﹤0.01% 2288
2020
Q2
Sell
-10,662
Closed -$38K 3818
2020
Q1
$38K Buy
+10,662
New +$38K ﹤0.01% 3344
2018
Q4
Sell
-6,488
Closed -$498K 3663
2018
Q3
$498K Sell
6,488
-4,875
-43% -$374K ﹤0.01% 2849
2018
Q2
$1.18M Buy
11,363
+5,713
+101% +$594K ﹤0.01% 2530
2018
Q1
$714K Buy
+5,650
New +$714K ﹤0.01% 2793